Daniela Tropea is an Associate Professor of Molecular Psychiatry at Trinity College Dublin. She is also part of the FutureNeuro Center in Ireland. Her lab studies the molecular mechanisms involved in brain function and plasticity in health and disease, with a particular focus on growth factors and insulin-like growth factor 1 (IGF-1). Beyond her scientific endeavors, Dr. Tropea is a dedicated educator and mentor. She received Trinity College Dublin’s Innovation in Teaching Award (2019) and the Irish Research Council’s Mentor Award (2022). She is also passionate about disseminating scientific knowledge to the public. She organizes the international meeting Biology of Brain Disorders, an event that fosters interactions between university students and leading researchers from both industry and academia, providing opportunities for networking and critical thinking. Furthermore, she collaborates with the Trinity Access Program to make scientific education accessible to primary school students from disadvantaged backgrounds. Dr. Tropea was a scholar in the Class of Science at the Scuola Normale Superiore in Pisa, Italy, from 1991 to 1996. In 2000, she earned her PhD in Neuroscience from the International School of Advanced Studies in Trieste, Italy. Before joining Trinity College Dublin in 2009, she was a postdoctoral researcher at the Massachusetts Institute of Technology (MIT) in Cambridge, MA, USA.
Emanuela Giacometti is Sr. Director in Philips Medical Systems where she focuses on developing research and service partnerships with large hospitals and diagnostic centres. Before joining Philips, Emanuela was a consultant in McKinsey & Company where she worked with executive clients in the Pharmaceutical sector. Emanuela also volunteers for medical startups and social ventures as a commercial and marketing advisor. During her university studies she worked in Novartis Friedrich Miescher Institute. She later obtained a PhD in Neuroscience from the University of Basel and conducting research at the Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology (MIT) in Cambridge, MA, USA. During her PhD she studied epigenetic control of gene expression in the brain. She maintains a strong interest in the neurosciences although she now pursues a career in business.